Trials / Active Not Recruiting
Active Not RecruitingNCT07107373
A Study to Assess the Treatment of Obstructive Hypertrophic Cardiomyopathy (oHCM) With Mavacamten in the US
MavAcamten Real World eVidEnce coLlaboration in HCM (MARVEL-HCM)
- Status
- Active Not Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 150 (estimated)
- Sponsor
- Bristol-Myers Squibb · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the real-world safety and effectiveness of patients with symptomatic obstructive hypertrophic cardiomyopathy (oHCM) initiated on mavacamten at certain high volume HCM centers in the US
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Mavacamten | According to the product label |
Timeline
- Start date
- 2023-12-22
- Primary completion
- 2024-07-26
- Completion
- 2025-12-31
- First posted
- 2025-08-06
- Last updated
- 2025-08-06
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT07107373. Inclusion in this directory is not an endorsement.